BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11069620)

  • 21. Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris.
    Ohyama M; Amagai M; Tsunoda K; Ota T; Koyasu S; Hata J; Umezawa A; Nishikawa T
    J Invest Dermatol; 2002 Jan; 118(1):199-204. PubMed ID: 11851895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
    Hashimoto T; Amagai M; Garrod DR; Nishikawa T
    Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of intramolecular epitope spreading in pemphigus vulgaris.
    Salato VK; Hacker-Foegen MK; Lazarova Z; Fairley JA; Lin MS
    Clin Immunol; 2005 Jul; 116(1):54-64. PubMed ID: 15925832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display.
    Payne AS; Ishii K; Kacir S; Lin C; Li H; Hanakawa Y; Tsunoda K; Amagai M; Stanley JR; Siegel DL
    J Clin Invest; 2005 Apr; 115(4):888-99. PubMed ID: 15841178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an enzyme-linked immunosorbent assay for detection of circulating IgG autoantibodies against canine desmoglein 3 in dogs with pemphigus.
    Nishifuji K; Tamura K; Konno H; Olivry T; Amagai M; Iwasaki T
    Vet Dermatol; 2009 Oct; 20(5-6):331-7. PubMed ID: 20178469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins.
    Langenhan J; Dworschak J; Saschenbrecker S; Komorowski L; Schlumberger W; Stöcker W; Westermann J; Recke A; Zillikens D; Schmidt E; Probst C
    Exp Dermatol; 2014 Apr; 23(4):253-9. PubMed ID: 24533885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transport to endoplasmic reticulum by signal peptide, but not proteolytic processing, is required for formation of conformational epitopes of pemphigus vulgaris antigen (Dsg3).
    Amagai M; Ishii K; Takayanagi A; Nishikawa T; Shimizu N
    J Invest Dermatol; 1996 Oct; 107(4):539-42. PubMed ID: 8823357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defective cell-cell adhesion in the epidermis.
    Stanley JR
    Ciba Found Symp; 1995; 189():107-20; discussion 120-3, 174-6. PubMed ID: 7587627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris.
    Kamiya K; Aoyama Y; Shirafuji Y; Hamada T; Morizane S; Fujii K; Iwatsuki K
    J Dermatol Sci; 2013 Jun; 70(3):190-5. PubMed ID: 23602628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a primary antigenic target of epitope spreading in endemic pemphigus foliaceus.
    Peng B; Temple BR; Yang J; Geng S; Culton DA; Qian Y
    J Autoimmun; 2021 Jan; 116():102561. PubMed ID: 33158670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic.
    Amagai M; Karpati S; Prussick R; Klaus-Kovtun V; Stanley JR
    J Clin Invest; 1992 Sep; 90(3):919-26. PubMed ID: 1522242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of chimeric molecules for recognition and targeting of antigen-specific B cells in pemphigus vulgaris.
    Proby CM; Ota T; Suzuki H; Koyasu S; Gamou S; Shimizu N; Wahl JK; Wheelock MJ; Nishikawa T; Amagai M
    Br J Dermatol; 2000 Feb; 142(2):321-30. PubMed ID: 10730768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cloning and protein expression of EC1-2 and EC3-4 epitopes of pemphigus vulgaris antigen.
    Zheng J; Kang X; Li W; Cheng Y; Tang M; Zhou W
    Chin Med J (Engl); 2000 Nov; 113(11):1011-4. PubMed ID: 11776114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
    Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
    J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmunity to desmocollin 3 in pemphigus vulgaris.
    Mao X; Nagler AR; Farber SA; Choi EJ; Jackson LH; Leiferman KM; Ishii N; Hashimoto T; Amagai M; Zone JJ; Payne AS
    Am J Pathol; 2010 Dec; 177(6):2724-30. PubMed ID: 20952584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of intravenous immunoglobulin therapy on autoantibody titers to desmoglein 3 and desmoglein 1 in pemphigus vulgaris.
    Sami N; Bhol KC; Ahmed RA
    Eur J Dermatol; 2003; 13(4):377-81. PubMed ID: 12948919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular domain of pemphigus vulgaris antigen (desmoglein 3) mediates weak homophilic adhesion.
    Amagai M; Kàrpàti S; Klaus-Kovtun V; Udey MC; Stanley JR
    J Invest Dermatol; 1994 Apr; 102(4):402-8. PubMed ID: 8043076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent.
    Amagai M; Ishii K; Hashimoto T; Gamou S; Shimizu N; Nishikawa T
    J Invest Dermatol; 1995 Aug; 105(2):243-7. PubMed ID: 7543549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.